How many institutions held GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value in Q4 2016?

50 institutional investors reported GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value for Q4 2016. Use the holders table for investor-level position and value details.

Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG)

Q: What does CUSIP 36315X101 represent in this 13F holders report?

CUSIP 36315X101 is the security identifier for GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value used to aggregate holder disclosures.

CUSIP: 36315X101

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class: Equity / Ordinary shares, no par value
Shares outstanding: 66,186,595
Total 13F shares: 9,985,219
Share change: +262,972
Total reported value: $641,996,000
Price per share: $64.19
Number of holders: 50
Value change: +$17,885,017
Number of buys: 27
Number of sells: 23

Quarterly Holders Quick Answers

What is CUSIP 36315X101?
CUSIP 36315X101 identifies GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2017
Previous quarter: Q3 2016

Recent filing periods for CUSIP 36315X101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	7%	4,616,982	$298,534,000	—	30 Sep 2016	13F
FEDERATED HERMES, INC.	13F	Company	1.7%	1,102,773	$71,305,000	—	30 Sep 2016	13F
EcoR1 Capital, LLC	13F	Company	0.76%	500,576	$32,367,000	—	30 Sep 2016	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.71%	468,982	$30,324,000	—	30 Sep 2016	13F
ORBIMED ADVISORS LLC	13F	Company	0.69%	457,900	$29,608,000	—	30 Sep 2016	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.64%	423,112	$27,358,000	—	30 Sep 2016	13F
Cormorant Asset Management, LP	13F	Company	0.5%	334,044	$21,441,000	—	30 Sep 2016	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.44%	289,338	$18,709,000	—	30 Sep 2016	13F
BAKER BROS. ADVISORS LP	13F	Company	0.39%	259,894	$16,805,000	—	30 Sep 2016	13F
Rock Springs Capital Management LP	13F	Company	0.32%	210,000	$13,579,000	—	30 Sep 2016	13F
Tekla Capital Management LLC	13F	Company	0.22%	147,738	$9,553,000	—	30 Sep 2016	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.21%	140,200	$9,065,000	—	30 Sep 2016	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.13%	85,000	$5,496,000	—	30 Sep 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.1%	66,940	$4,327,000	—	30 Sep 2016	13F
DAFNA Capital Management LLC	13F	Company	0.1%	66,068	$4,272,000	—	30 Sep 2016	13F
MORGAN STANLEY	13F	Company	0.1%	63,406	$4,100,000	—	30 Sep 2016	13F
Bank of New York Mellon Corp	13F	Company	0.1%	63,087	$4,080,000	—	30 Sep 2016	13F
ALPS ADVISORS INC	13F	Company	0.09%	58,782	$3,801,000	—	30 Sep 2016	13F
Atika Capital Management LLC	13F	Company	0.08%	52,000	$3,362,000	—	30 Sep 2016	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.08%	52,000	$3,362,000	—	30 Sep 2016	13F
J. Goldman & Co LP	13F	Company	0.08%	50,000	$3,233,000	—	30 Sep 2016	13F
CLOUGH CAPITAL PARTNERS L P	13F	Company	0.07%	48,170	$3,115,000	—	30 Sep 2016	13F
WILLIAMS JONES & ASSOCIATES LLC	13F	Company	0.07%	44,757	$2,894,000	—	30 Sep 2016	13F
NORTHERN TRUST CORP	13F	Company	0.02%	14,673	$949,000	—	30 Sep 2016	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.02%	13,000	$841,000	—	30 Sep 2016	13F
P.A.W. CAPITAL CORP	13F	Company	0.02%	12,000	$776,000	—	30 Sep 2016	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.01%	9,398	$608,000	—	30 Sep 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.01%	8,793	$569,000	—	30 Sep 2016	13F
UBS Group AG	13F	Company	0.01%	7,762	$502,000	—	30 Sep 2016	13F
CITADEL ADVISORS LLC	13F	Company	0.01%	6,374	$412,000	—	30 Sep 2016	13F
MARSHALL WACE, LLP	13F	Company	0.01%	6,029	$390,000	—	30 Sep 2016	13F
Fiera Capital Corp	13F	Company	0.01%	3,842	$248,000	—	30 Sep 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	3,681	$238,000	—	30 Sep 2016	13F
Rail-Splitter Capital Management, LLC	13F	Company	0.01%	3,649	$236,000	—	30 Sep 2016	13F
Polar Asset Management Partners Inc.	13F	Company	0.01%	3,500	$226,000	—	30 Sep 2016	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.01%	3,434	$222,000	—	30 Sep 2016	13F
CASTLEARK MANAGEMENT LLC	13F	Company	0.01%	3,330	$215,000	—	30 Sep 2016	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0%	2,412	$156,000	—	30 Sep 2016	13F
Advisors Preferred, LLC	13F	Company	0%	2,019	$131,000	—	30 Sep 2016	13F
Creative Planning	13F	Company	0%	1,200	$78,000	—	30 Sep 2016	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	1,002	$64,000	—	30 Sep 2016	13F
Walleye Trading LLC	13F	Company	0%	800	$52,000	—	30 Sep 2016	13F
Advisor Group, Inc.	13F	Company	0%	705	$46,000	—	30 Sep 2016	13F
Acrospire Investment Management LLC	13F	Company	0%	700	$45,000	—	30 Sep 2016	13F
Geneos Wealth Management Inc.	13F	Company	0%	400	$25,000	—	30 Sep 2016	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	304	$20,000	—	30 Sep 2016	13F
BANK OF MONTREAL /CAN/	13F	Company	0%	22	$1,000	—	30 Sep 2016	13F

Institutional Holders of Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG) as of Q4 2016

As of 31 Dec 2016, Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,985,219 shares. The largest 10 holders included FMR LLC, FEDERATED INVESTORS INC /PA/, EcoR1 Capital, LLC, DEERFIELD MANAGEMENT CO, WELLINGTON MANAGEMENT GROUP LLP, Cormorant Asset Management, LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, and GOLDMAN SACHS GROUP INC. This page lists 50 institutional shareholders reporting positions in this security for the Q4 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders

Q4 2016 holders

Holder diff

Investor	Q3 2016 Shares	Q4 2016 Shares	Share Diff	Share Chg %	Q3 2016 Value $	Q4 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.